170
Participants
Start Date
February 3, 2023
Primary Completion Date
February 21, 2024
Study Completion Date
December 31, 2024
Early diagnosis for Pancreatic Cancers in high-risk asymptomatic subject groups
Early diagnosis for Pancreatic Cancers in high-risk asymptomatic subject groups by developing and validating a comprehensive cancer risk prediction algorithm (CRPA) as a clinical support tool to calculate a personalized risk profile
Toulouse University Hospital, Toulouse
European Institute of Oncology, Milan
"Oncological Institute Prof. Dr. Ion Chiricuta", Cluj-Napoca
Catalan Institute of Oncology, Barcelona
European Institute of Oncology
OTHER